ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31

ANGIODYNAMICS INC

Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026

$11.39+0.15 (+1.33%)

Close on Oct 19, 2026

Community

Notes and questions about Angiodynamics from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Angiodynamics's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ANGO.

Revenue growth8.2% · median 13.9%

Gross margin55.7% · median 72.9%

Operating margin-11.2% · median 2.3%

Net margin-10.1% · median 0.6%

Advertisement
300 × 250